GE bacteria could lead to better vaccines

Researchers at The University of Texas at Austin have developed a menu of 61 new strains of genetically engineered bacteria that may improve the efficacy of vaccines for diseases such as flu, pertussis, cholera and HPV.

The strains of E. coli, which were described in a paper published this month in the journal PNAS, are part of a new class of biological “adjuvants” that is poised to transform vaccine design. Adjuvants are substances added to vaccines to boost the human immune response.

Related on the SLP

No related posts.

‘A new frontier’: Though scorned by RFK Jr., personalized mRNA vaccine offers hope for many suffering from melanoma skin cancer

A ‘shining success’ or ’empty promises’: Two years along, West Virginians assess MAHA’s food promises

Pennsylvania tells doctors to prepare for a surge in newborn measles cases—a complication unseen in decades

View the original article here: Designer Bacteria May Lead to Better Vaccines